HIV pregnancy study tests safer drug combo to protect newborns
NCT ID NCT00424814
First seen Apr 13, 2026 · Last updated Apr 25, 2026 · Updated 1 time
Summary
This study tested a two-drug HIV treatment (lopinavir/ritonavir) in 105 pregnant women with HIV to see if it could prevent mother-to-child transmission while reducing side effects from standard three-drug combos. The goal was to keep the mother's virus level low before delivery. Results help guide safer options for mothers and babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Pitie salpetriere
Paris, 75013, France
Conditions
Explore the condition pages connected to this study.